{"title":"Inhibition of antagonist binding to human brain muscarinic receptor by vanadium compounds.","authors":"H Venters, T A Ala, W H Frey","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Metavanadate, orthovanadate, and pervanadate all inhibited [3H]QNB antagonist binding to the human brain muscarinic acetylcholine receptor (mAChR) in the presence of glutathione, with the order of decreasing potency and the concentration required for 50% inhibition (I[50]) being: pervanadate (95 microM) > orthovanadate (132 microM) > metavanadate (452 microM). Omission of glutathione decreased the inhibition of the vanadium compounds 2-6-fold. Preincubating the vanadium compounds with the mAChR in the presence of glutathione at 37 degrees for 1 h markedly decreased the I(50) values as follows: pervanadate (13 microM) > orthovanadate (46 microM) > metavanadate (118 microM). Inhibition by the vanadium compounds was blocked by EDTA, Mn2+, and Trolox, a water-soluble vitamin E analog. Vanadium use in treating diabetes is discussed regarding its inhibition of mAChR function.</p>","PeriodicalId":79456,"journal":{"name":"Receptors & signal transduction","volume":"7 3","pages":"137-42"},"PeriodicalIF":0.0000,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Receptors & signal transduction","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Metavanadate, orthovanadate, and pervanadate all inhibited [3H]QNB antagonist binding to the human brain muscarinic acetylcholine receptor (mAChR) in the presence of glutathione, with the order of decreasing potency and the concentration required for 50% inhibition (I[50]) being: pervanadate (95 microM) > orthovanadate (132 microM) > metavanadate (452 microM). Omission of glutathione decreased the inhibition of the vanadium compounds 2-6-fold. Preincubating the vanadium compounds with the mAChR in the presence of glutathione at 37 degrees for 1 h markedly decreased the I(50) values as follows: pervanadate (13 microM) > orthovanadate (46 microM) > metavanadate (118 microM). Inhibition by the vanadium compounds was blocked by EDTA, Mn2+, and Trolox, a water-soluble vitamin E analog. Vanadium use in treating diabetes is discussed regarding its inhibition of mAChR function.
在谷胱甘肽存在的情况下，元钒酸盐、原钒酸盐和过钒酸盐均能抑制[3H]QNB拮抗剂与人脑毒菌碱乙酰胆碱受体(mAChR)的结合，其效价递减的顺序和50%抑制所需的浓度(I[50])为:过钒酸盐(95 μ m) >原钒酸盐(132 μ m) >元钒酸盐(452 μ m)。省略谷胱甘肽使钒化合物的抑制作用降低2-6倍。在谷胱甘肽存在下，用mAChR在37度下预温1 h显著降低了钒化合物的I(50)值，其顺序为:过钒酸盐(13微米)>正钒酸盐(46微米)>偏钒酸盐(118微米)。钒化合物的抑制作用被EDTA、Mn2+和Trolox(一种水溶性维生素E类似物)阻断。本文讨论了钒在糖尿病治疗中的应用，探讨了钒对糖尿病的抑制作用。
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
